HARPREET KAUR: Open Payments
NPI 1962914143 · CHARLTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 15 payments from 10 companies in 2025. Trend: 2023 $288 · 2024 $109 · 2025 $520
Food & beverage: $470Long term medical supply or device loan: $50
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $180 |
| Novo Nordisk Inc | 2 | $55 |
| Tandem Diabetes Care, Inc. | 3 | $53 |
| Abbott Laboratories | 1 | $50 |
| Lilly USA, LLC | 2 | $46 |
| Insulet Corporation | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
| Amgen Inc. | 1 | $27 |
| SANOFI-AVENTIS U.S. LLC | 1 | $26 |
| CeQur Corporation | 1 | $20 |
Products named: MINIMED 780G, t:slim X2 Insulin Pump with Control-IQ, FREESTYLE INSULINX, MOUNJARO, OMNIPOD, Rybelsus, Kerendia, EVENITY.
Industry payments across MA — which companies pay providers there.
